Jacobs receives EPCM contract from Novartis

July 3, 2007 — /PRNewswire-FirstCall/ — PASADENA, CA — Jacobs Engineering Group Inc. announced today that it is providing engineering, procurement, and construction management services for Novartis’ new manufacturing facility to be located in Holly Springs, NC. Officials did not disclose the contract value.

The new facility will produce trivalent pandemic and interpandemic influenza vaccines utilizing an innovative cell culture based process for U.S. and overseas markets. Jacobs is providing services on-site and from its Cincinnati office.

In making the announcement, Jacobs group vice president Arlan Emmert states, “Flu pandemics are by their nature global issues. We are pleased to be playing this significant role preparing for a potential pandemic with a premier global vaccine producer like Novartis.”

Jacobs, with over 46,000 employees and revenues exceeding $8.0 billion, provides technical, professional, and construction services globally.

Source: Jacobs Engineering Group Inc.

Mary Bloom of Jacobs Engineering Group Inc., +1-626-578-6992
Web site: http://www.jacobs.com/


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.